Company Overview and News

6
Friday’s Biggest Winners and Losers in the S&P 500

2018-10-13 247wallst
Friday was a solid day for the broad U.S. markets, bouncing back from the devastating drop on Wednesday and Thursday. Each of the major averages gained over 1% in the session with the Nasdaq posting the strongest performance. Crude oil posted a nice gain in Friday’s session but still ended the week lower. The S&P 500 sectors were entirely positive. The most positive sectors were technology, consumer discretionary, and health care up 3.
FTRPR NFLX FTR

31
FDL: Take A Dive Into This Dividend Fund

2018-10-12 seekingalpha
With the tech rotation turning into a rout, value stocks and dividend payers have outperformed, but buyers beware of what's under the hood.
IBM GE GEC PFG XOM IWD MET M SPHD FTRPR T CVX VZ GNE PEY FTR

95
16 Stocks to Buy Before They Turn It Around

2018-10-12 investorplace - 6
In any market — bull or bear — investors can always find turnaround stocks to buy. Companies are no more perfect than the humans that comprise them, after all. Mergers go south. Poor management can decimate morale. Sometimes, the world changes — and it takes a few years for a business to catch up.
LOW JCP CHKVP UAA CHKVZ TTS BHC SHLD NKE KMI VSI KMR CVB GE FTD CBS.WD CMG GPRO MAT CHK VZ CPV BATRA FTR LSXMB HD FIT BATRK CPB LSXMA FND BATRR CHKDH CHKDG VZA CHKDJ VRX CHKDP FTRPR GRMN AAPL BATRB CBS VIA CKRGZ GEC FWONB CBS.A QRTEA M FLWS FWONA CHKWZ UA HAS CHK.WI KHC FWONK GNE LSXMK KMRFZ DHR

6
Frontier Communications (FTR) to Launch New Gigabit Service

2018-10-10 zacks
In order to augment its Fiber broadband services in regional emerging markets, Frontier Communications Corporation (FTR - Free Report) recently announced that it is bringing a new Gigabit service in its FiOS and Vantage Fiber markets. The company aims to offer its fastest residential broadband service, increasing new consumer broadband service to 200/200 megabits per second (Mbps) as well as add higher speeds in Indiana, Oregon and Washington with 300/300 Mbps.
FTRPR BKHU BKH FTR AQN

17
AT&T: Xandr Appears Mostly Hype

2018-10-08 seekingalpha
Last week, AT&T (T) ushered in the aggressive move into advertising. The wireless giant hopes to more effectively compete in the advertising sector against the tech giants by collecting more data from customers via various video and wireless connections. Unfortunately, the newly created Xandr is more likely to resemble the failure of Oath from Verizon Communications (VZ).
WFC WFCNP FB VZA FTRPR GOOGL VZ FTR ATUS ALV.WI

6
Frontier Communication: Short Attack Continues

2018-10-07 seekingalpha
About 60% of its overall float stood shorted at the end of the most recent reporting cycle, which is extremely high by industry standards.
FTRPR WIN FTR

 
FTRPR / Frontier Communications Corp. / BlackRock Inc. - null (Passive Investment)

2018-10-05 sec.gov
us35906a3068_100518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 8 ) FRONTIER COMMUNICATIONS CORPORATION -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 35906A306 -------------------------------------------------------- (CUSIP Number) July 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder
FTRPR

 
FTRPR / Frontier Communications Corp. / BlackRock Inc. - null (Passive Investment)

2018-10-05 sec.gov
us35906a3068_100518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 8 ) FRONTIER COMMUNICATIONS CORPORATION -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 35906A306 -------------------------------------------------------- (CUSIP Number) July 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder
FTRPR

6
AT&T Extends Footprint Across Markets to Boost Top Line

2018-09-26 zacks
AT&T Inc. (T - Free Report) recently announced that it is expanding Business Wi-Fi service by adding 60 countries to its long list of beneficiaries to help businesses stay better connected and seamlessly run critical operations. The company also stated that more countries will be added in the future.
FTRPR FTR ATUS ALV.WI

6
[Press] Global Women Petroleum & Energy Club Announces Partnership with Future Energy Africa 2018

2018-09-25 oilvoice
The Global Women Petroleum & Energy Club with the Future Energy Africa Oil & Gas Exhibition & Conference 2018 announces a strategic partnership at its inaugural exhibition & conference in Cape Town and will co-host the Business Luncheon in Africa during the 3-day event. The Luncheon will take place on Tuesday 2 October 2018 at CTICC 2, Cape Town, South Africa.
FTRPR FTR

10
Amazon And XLY: Time To Move On

2018-09-24 seekingalpha
Investors who ignore the Global Industry Classification Standard (GICS) risk could be missing out, but a bigger risk is too much of a good thing.
BRK.A STT FTRPR RTH VCR FTR

6
Frontier Communications Is Uninvestable

2018-09-18 seekingalpha
Until the company starts showing robust signs of operational or financial growth, the downward spiral in its shares may continue.
FTRPR FTR

6
Monday’s Biggest Winners and Losers in the S&P 500

2018-09-17 247wallst
September 17, 2018: The S&P 500 closed down 0.6% at 2,888.95. The DJIA also closed down 0.4% at 26,062.02. Separately, the Nasdaq was down 1.4% at 7,895.79.
FTRPR ABMD FTR

7
Traders Beware: Potential Buying Opportunity In A Leveraged Bet On High Yield

2018-09-17 seekingalpha - 1
The fundamentals have been flailing as of late but there is some potential here for those that are brave enough to try.
FTRPR FTR

6
Even If We Give Windstream The Benefit Of The Doubt, This Story Doesn't Have A Happen Ending

2018-09-14 seekingalpha
I'm not big on technical analysis, but sometimes the signs are too obvious. Windstream is a perfect example.
FTRPR WIN FTR

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 35906A207